Porphyromonas gingivalis gingipain cysteine protease (Gingipain)

Gingipains are a group of essential cysteine proteases secreted by the anaerobic bacterium Porphyromonas gingivalis, a primary pathogen in chronic periodontitis. These enzymes, categorized into arginine-specific (RgpA and RgpB) and lysine-specific (Kgp) types, are critical for the bacterium's survival, facilitating nutrient acquisition through the degradation of host proteins and enabling immune evasion by cleaving complement factors and cytokines (Potempa et al., 2003, PubMed: 12614153). Beyond their role in oral disease, gingipains have been identified as significant virulence factors in systemic conditions, most notably Alzheimer's disease, where they have been detected in the brains of patients and are hypothesized to contribute to neurodegeneration through the cleavage of tau and other neuronal proteins (Dominy et al., 2019, PubMed: 30679222). Therapeutic targeting of gingipains involves the use of small-molecule inhibitors designed to block their catalytic activity, thereby reducing bacterial toxicity and associated inflammatory damage. While clinical development has faced hurdles, such as the failure of atuzaginstat in Phase 2/3 trials for Alzheimer's, these proteases remain a focal point for research into the link between oral pathogens and systemic inflammatory disorders.

Other names

RgpARgpBKgpArginine-specific gingipainLysine-specific gingipainGingipain RGingipain KPorphyromain

Irreversible or reversible inhibition of the protease active site to prevent host protein cleavage and bacterial virulence.